Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Akua Afriyie Karikari, Rhonda L. McFleder, Eliana Ribechini, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 194-210
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 545
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen Xu, Yong Chen, Yang Xu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 50
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
Daniel Torrente, Enming J. Su, Alí Francisco Citalán‐Madrid, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
Alexander Grotemeyer, Rhonda L. McFleder, Jingjing Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Johanne Lauritsen, Marina Romero‐Ramos
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 863-878
Open Access | Times Cited: 31
Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management
Yueyue Guan, Guo-hua Tang, Lei Li, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 2, pp. 146-164
Open Access | Times Cited: 14
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Adithya Gopinath, Phillip Mackie, Basil Hashimi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
Alexander Grotemeyer, Judith F. Fischer, James B. Koprich, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 7
Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
Yangzhi Xie, Liang Chen, Jiacheng Chen, et al.
Brain and Behavior (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Mohammad Badr, Rhonda L. McFleder, Jingjing Wu, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 23
Telomerase reverse transcriptase and neurodegenerative diseases
Xin Yu, Mengmeng Liu, Caiyun Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110668-110668
Open Access | Times Cited: 13
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease
Lisa Rauschenberger, J. Behnke, Alexander Grotemeyer, et al.
Neurobiology of Disease (2022) Vol. 171, pp. 105798-105798
Open Access | Times Cited: 19
Brain-to-gut trafficking of alpha-synuclein by CD11c+ cells in a mouse model of Parkinson’s disease
Rhonda L. McFleder, A. Makhotkina, Janos Groh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis
Shir Zaccai, Anna Nemirovsky, Livnat Lerner, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Innate and adaptive immunity in neurodegenerative disease
Yeyu Huang, Guoxin Zhang, Sheng Li, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Listerin promotes α-synuclein degradation to alleviate Parkinson’s disease through the ESCRT pathway
Fei Qin, R. Cao, Wenjing Cui, et al.
Science Advances (2025) Vol. 11, Iss. 7
Closed Access
Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson’s disease: A systematic review of preclinical studies
Xuesong Wang, Yue Wang, Yan Xu, et al.
World Journal of Stem Cells (2025) Vol. 17, Iss. 4
Closed Access
Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
The role of antiviral CD8+ T cells in cognitive impairment
Katie L. Reagin, Kristen E. Funk
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102603-102603
Open Access | Times Cited: 18
Analysis of the Relationship Between Parkinson’s Disease and Diabetic Retinopathy Based on Bioinformatics Methods
XinYu Shi, YiNi Wang, YaPing Yin, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6395-6406
Closed Access | Times Cited: 3
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease
Jasna Šaponjić, Rebeca Mejı́as, Neda Nikolovski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4330-4330
Open Access | Times Cited: 3
An accelerated Parkinson’s disease monkey model using AAV-α-synuclein plus poly(ADP-ribose)
Shuyi Liu, Nan Yang, Yaping Yan, et al.
Cell Reports Methods (2024), pp. 100876-100876
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top